Evaluation of Maternal Complications in Severe Preeclampsia in a University Hospital in Tirana by Ndoni, Eriseida et al.
 
OA Maced J Med Sci electronic publication ahead of print,  
published on February 24, 2016 as http://dx.doi.org/10.3889/oamjms.2016.025 
_______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci.                                                                                                                                                                                                                          1 
 
ID Design 2012/DOOEL Skopje 
Open Access Macedonian Journal of Medical Sciences. 
http://dx.doi.org/10.3889/oamjms.2016.025 
eISSN: 1857-9655 
Clinical Science 
  
 
 
 
Evaluation of Maternal Complications in Severe Preeclampsia in 
a University Hospital in Tirana 
 
 
Eriseida Ndoni
1*
, Redi Hoxhallari
2
, Astrit Bimbashi
1
 
 
1
University Hospital of Obstetrics and Gynecology “Koço Gliozheni”, Tirana, Albania; 
2
Italian Clinic “San Antonio”, Tirana, 
Albania 
 
Citation: Ndoni E, Hoxhallari R, Bimbashi A. Evaluation 
of Maternal Complications in Severe Preeclampsia in a 
University Hospital in Tirana. OA Maced J Med Sci. 
http://dx.doi.org/10.3889/oamjms.2016.025 
Key words: severe preeclampsia; eclampsia; HELLP 
syndrome; stroke; pulmonary edema; maternal outcome. 
*
Correspondence: Dr. Eriseida Ndoni. University Hospital 
of Obstetrics and Gynecology "Koco Gliozheni", 
Obstetrics and Gynecology, Bulevardi "Bajram Curri", 
Tirana 1001, Albania. Phone: 00355692160629. E-Mail: 
erisandoni@yahoo.com 
Received: 21-Jan-2016; Revised: 17-Feb-2016; 
Accepted: 18-Feb-2016; Online first: 24-Feb-2016 
Copyright: © 2016 Eriseida Ndoni, Redi Hoxhallari, Astrit 
Bimbashi. This is an open access article distributed under 
the terms of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author 
and source are credited. 
Competing Interests: The authors have declared that no 
competing interests exist. 
 
 
 
 
 
 
 
 
 
 
Abstract  
BACKGROUND: Preeclampsia is a hypertensive multisystem disorder of pregnancy that 
complicates up to 10% of pregnancies worldwide and is one of the leading causes of maternal and 
perinatal morbidity and mortality.  
AIM: To evaluate maternal complications associated with severe preeclampsia.  
METHODS: This is a retrospective cross-sectional study conducted in the UHOG “Koço Gliozheni”, 
in Tirana. Primary outcomes evaluated: maternal death, eclampsia, stroke, HELLP syndrome, and 
pulmonary edema. Secondary outcomes: renal failure, admission in ICU, caesarean section, 
placental abruption, and postpartum hemorrhage. Fisher’s exact test and Chi-squared test were 
used as statistical methods.  
RESULTS: In women with severe preeclampsia we found higher rates of complications comparing 
to the group with preeclampsia. Eclampsia (1.5% vs. 7.1%, P < 0.001), HELLP syndrome (2.4% vs. 
11.0%; P < 0.001), stroke (0.5% vs 1.9%, P = 0.105) pulmonary edema (0.25% vs. 1.3%, P = 
0.0035), renal failure (0.9% vs. 2.6%, P = 0.107), admission in ICU (19.5% vs. 71.4%, P = 0.007), 
caesarean section rates (55.5% vs. 77%, P = 0.508), placental abruption (4.3% vs. 7.8%, P = 
0.103) and severe postpartum hemorrhage (3.2% vs. 3.9%, P = 0.628).  
CONCLUSION: Severe preeclampsia is associated with high rates of maternal severe morbidity 
and early diagnosis and timely intervention can prevent life treating complications. 
 
 
 
 
 
 
 
Introduction 
 
Preeclampsia is a hypertensive multisystem 
disorder of pregnancy that complicates up to 10% of 
pregnancies worldwide and is one of the leading 
causes of maternal and perinatal morbidity and 
mortality [1]. Hypertension in pregnancy should be 
defined as a systolic blood pressure ≥ 140 mmHg 
and/or diastolic blood pressure ≥ 90 mmHg, based on 
the average of at least 2 measurements, taken at 
least 15 minutes apart, using the same arm [2]. The 
diagnostic criteria of preeclampsia used to be de novo 
hypertension after 20 weeks of pregnancy and 
proteinuria (exceeding 300 mg of total protein in a 24-
hour urine collection) [3]. Recently, Royal College of 
Obstetricians and Gynecologists (RCOG) have 
proposed another mode of proteinuria assessment, 
using spot urine measuring the protein to creatinine 
ratio. According to the fact that preeclampsia is 
considered a multi-system disorder, the diagnostic 
criteria such as hypertension and proteinuria alone is 
not sufficient for clinical practice. Hence, this disease 
can be presented in several ways and it is necessary 
to asses all the symptoms and signs that are 
suggestive for the presence of the disease. The above 
mentioned facts has led to widening of the 
preeclampsia deﬁnition including: de novo 
hypertension after 20 weeks’ gestation and new onset 
of one of the following: a) proteinuria as deﬁned 
above; b) renal insufﬁciency (creatinine > 0.09 
mmol/L, or oliguria; c) liver disease (elevated 
transaminases and/or severe right upper quadrant or 
epigastric pain); d) neurological problems, convulsions 
(eclampsia), hyperreﬂexia with clonus, severe 
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headaches, persistent visual disturbances; e) 
hematological disturbances: thrombocytopenia, DIC 
(Disseminated Intravascular Coagulation), hemolysis; 
or f) fetal growth restriction [4]. 
According to American College of Obstetrics 
and Gynecology (ACOG) diagnostic criteria, the 
diagnosis of severe preeclampsia includes severe 
hypertension (systolic blood pressure ≥ 160 mmHg or 
diastolic blood pressure ≥ 110 mmHg, or both), 
neurological disturbances (such as headache, visual 
disturbances, and exaggerated tendon reflexes), 
epigastric or right upper quadrant pain, oliguria (less 
than 500 mL in 24 hours), pulmonary edema, 
cyanosis, impaired liver function, thrombocytopenia or 
intrauterine growth restriction (IUGR) [5].  
Preeclampsia and eclampsia account for 10–
15% of maternal deaths worldwide [6]. A majority of 
deaths in developing countries result from eclampsia, 
meanwhile in developed countries result from the 
complications of preeclampsia (HELLP syndrome, 
eclampsia, DIC, renal failure, pulmonary edema) [7]. 
HELLP syndrome occurs in 0.1%-0.6% of all 
pregnancies and in 4%-12% of patients with 
preeclampsia. HELLP syndrome typically occurs 
between week 27 of gestation and delivery, or 
immediately postpartum in 15%-30% of cases [8, 9]. 
Eclampsia refers to the occurrence of new-onset, 
generalized, tonic-clonic seizures or coma in a woman 
with preeclampsia. Despite advances in detection and 
management, eclampsia remains a common cause of 
maternal morbidity and death.  
Disseminated intravascular coagulation (DIC) 
was defined as platelet count < 100 000/mm
3
, plasma 
fibrinogen <3 g/L, and fibrin degradation products > 40 
mg/dL [10]. The prevalence of DIC in pregnancy 
ranges from 0.03 to 0.35 percent in population-based 
studies [11].  
Acute renal failure was diagnosed in the 
presence of oliguria or anuria in association with a 
creatinine clearance ≤ 20 mL/min or serum creatinine 
≥ 2 mg/dL. Pulmonary edema is a rare and serious 
problem that complicates about 3 % of cases of 
severe preeclampsia [7]. 
The objective of this study is to evaluate 
major maternal complications associated with 
preeclampsia and severe preeclampsia. 
 
 
 
Material and Methods 
 
This is a retrospective case control study 
conducted in the University Hospital of Obstetrics and 
Gynecology (UHOG) “Koço Gliozheni”, in Tirana. To 
collect the data for this study we used the medical 
records of deliveries from January 2009 until 
December 2013. 
This study was approved by Institutional 
Review Board of UHOG “Koço Gliozheni”. Written 
informed consent was not obtained from pregnant 
women involved in this study, because it was a 
retrospective research and it was not possible to get 
the informed consent from every patient. The data 
collected for this study are anonymous.  
The standard inclusion criteria in the study 
were pregnant women diagnosed with preeclampsia 
that had delivered in this hospital after 24 weeks 
gestation during the period mentioned above, despite 
the number of the babies, fetal presentation and mode 
of delivery.  
The calculation of gestational age was made 
based on the first day of the last menstruation period 
(LMP – 13% of cases), on the early ultrasound 
examination (before 13 weeks gestation – 11% of 
cases) or based in the combination of both criteria 
(LMP and first ultrasound examination – 76% of 
cases).  
The exclusion criteria in this study were: 
pregnancies with confirmed fetal lethal anomalies, 
pregnancies with missing data necessary for the 
study, pregnancies with inaccurate gestational age.  
The variables collected from the medical 
records were: maternal age, parity, first day of the last 
menstruation (LPM), gestational age at the moment of 
severe preeclampsia diagnosis, gestational age at 
delivery, highest diastolic/systolic BP, medical 
treatment (antihypertensives, anticonvulsants, 
corticoids) as well as labor and delivery – 
spontaneous, induced or caesarean section (see 
Table 1).  
Table 1: Maternal variables included in the study 
Maternal variables   
Maternal age  
Parity 
First day of the last menstruation (LPM) 
Gestational age at the moment of severe preeclampsia diagnosis 
Gestational age at delivery 
Highest diastolic BP,  Highest systolic BP 
Highest proteinuria level  
Medical treatment (antihypertensives, anticonvulsants, corticoids) 
Labor and delivery – spontaneous, induced, caesarean section 
 
 
The maternal outcomes measured were:  
Primary outcomes that include: maternal 
mortality, eclampsia, stroke, HELLP syndrome 
(hemolysis, elevated liver enzymes and low platelets), 
and pulmonary edema. Pulmonary edema was 
assessed based on clinical findings and chest 
radiography. 
Secondary outcomes that include: renal 
failure, admission in ICU (Intensive Care Unit), 
caesarean section, placental abruption, and 
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postpartum hemorrhage. Renal failure was diagnosed 
when oliguria or anuria in association with an elevated 
serum creatinine level ≥ 2 mg/dL. 
All the data were collected in excel format and 
were checked for their completeness and accuracy. 
The evaluated variables were compared between the 
preeclampsia group and the severe preeclampsia 
group.  
The statistical analysis was made using SPSS 
program. Differences between groups for categorical 
variables were examined with Fisher’s exact test. In 
the situations with large numeric data of the variables 
we have used the “Chi-squared” test. 
 
 
Results 
 
The total number of deliveries for this 5 years 
period (January 2009 until December 2013) was 
21,795. After a careful investigation of medical 
records, were identified 1274 cases hospitalized with 
hypertensive disorders, of which 897 were diagnosed 
with preeclampsia.  
Based on the exclusion criteria we found 27 
pregnancies with confirmed fetal lethal anomalies, 99 
pregnancies with missing data necessary for the study 
(in the medical records there were not all the available 
data for the variables included in the study), 28 
pregnancies with inaccurate determination of 
gestational age (the patient doesn’t know the LMP 
and/or hasn’t done an ultrasound examination in the 
first trimester).  
After the application of the exclusion criteria, a 
total of 743 cases with preeclampsia were included in 
this study. Based on ACOG classification criteria 
(2013) for the severity of the diseases we found 154 
cases with severe preeclampsia (0.7% of the total 
births of the study period and 20.7% of all cases with 
preeclampsia). 
Taking into consideration the fact that our 
study extends in a 5-year period, the population 
available to this study do not allow for analysis of 
maternal mortality. For this reason, regardless of 
maternal mortality is considered as the most important 
parameter in the evaluation of maternal outcome, 
referring to the small sample of this study, it was 
impossible the statistical processing of the results on 
this variable.  
Eclampsia and HELLP syndrome are 
considered almost exclusively as unique 
complications of preeclampsia. For this reason the 
number of cases with eclampsia and HELLP 
syndrome is equal in both preeclampsia and severe 
preeclampsia groups. 
 
Primary maternal outcomes 
In Table 2 are presented the major maternal 
complications in cases with preeclampsia and severe 
preeclampsia (primary outcomes) and comparison 
was done between the two the groups for all the 
outcomes. In this comparison we noted a statistically 
significant difference for the presence of eclampsia 
(1.5% vs. 7.1%, for total preeclampsia group vs. 
severe preeclampsia group respectively; P < 0.001). 
The same significance was observed even for HELLP 
syndrome (2.4% vs. 11.0%; P < 0.001). Stroke and 
pulmonary edema were more frequent in the severe 
preeclampsia group but this difference was not 
statistically significant (P = 0.105 and P = 0.0035 
respectively). 
Table 2: Primary maternal outcomes in severe preeclampsia 
and in total cases with preeclampsia 
Primary maternal 
outcomes 
Total preeclampsia 
n (%) 
Severe preeclampsia 
n (%) 
P value 
Eclampsia 11/743 (1.5%) 11/154 (7.1%) P < 0.001 
HELLP syndrome 18/743 (2.4%) 18/154 (11.0%) P < 0.001 
Stroke 4/743 (0.5%) 3/154 (1.9%) P = 0.105 
Pulmonary edema 2/743 (0.25%) 2/154 (1.3%) P = 0.0035 
 
 
Secondary maternal outcomes  
In Table 3 are presented the rates of 
secondary outcomes for both groups. In the 
comparison between the two groups we noted a 
statistically significant difference for the admission in 
ICU (19.5% vs. 71.4%, for total preeclampsia group 
vs. severe preeclampsia group respectively; P = 
0.007).  
Table 3: Secondary maternal outcomes in severe preeclampsia 
and in total cases with preeclampsia 
Secondary maternal 
outcomes 
Total preeclampsia 
n (%) 
Severe preeclampsia 
n (%) 
P value 
Renal failure 7/743 (0.9%) 4/154 (2.6%) P = 0.107 
Admission in ICU 145/743 (19.5%) 110/154 (71.4%) P = 0.007 
Caesarean section 413/743 (55.5%) 118/154 (77%) P = 0.508 
Placental abruption 32/743 (4.3%) 12/154 (7.8%) P = 0.103 
Severe PPH* 24/743 (3.2%) 6/154 (3.9%) P = 0.628 
*Severe Postpartum hemorrhage (> 1000 mL).  
 
The rate of renal failure resulted higher in 
women with severe preeclampsia than in women with 
preeclampsia, but the difference was not significant 
(0.9% vs. 2.6%, P = 0.107). The same results we had 
even for caesarean section rates (55.5% vs. 77%, P = 
0.508), placental abruption (4.3% vs. 7.8%, P = 0.103) 
and severe postpartum hemorrhage (3.2% vs. 3.9%, 
P = 0.628). 
 
 
Discussion 
 
Pre-eclampsia constitutes a major source of 
morbidity and mortality worldwide. Overall, 10%–15% 
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of maternal deaths are directly associated with severe 
preeclampsia and eclampsia [6]. Although maternal 
mortality is a very important parameter in the 
evaluation of maternal outcome, referring to the small 
sample study, we considered impossible the statistical 
processing of the results on this variable. 
Maternal complications generally correlated 
with the severity of preeclampsia. In our study we 
found that 1.5% of all preeclamptic women and 7.1% 
of all severe preeclamptic women were complicated 
by eclamptic seizures. In a previous study, Liu et al. 
demonstrated that 9.34% of cases with severe 
preeclampsia had eclampsia [12], which is slightly 
higher than our results.  
Our study showed that, 2.4% of cases with 
preeclampsia and 11% of cases with severe 
preeclampsia had HELLP syndrome. Also Murphy and 
Stirrat found that 21% of cases with severe 
preeclampsia had HELLP syndrome which is almost 
the double of our result (21% vs. 11%) [13]. 
In our study we found stroke in 0.5% of cases 
with preeclampsia and 1.9% of cases with severe 
preeclampsia. Comparing to the literature in the 
PIERS study CNS complications were found 7 from 
2020 cases with preeclampsia (0.35%), similar to our 
result for the preeclampsia group [14]. 
As well, our study we found pulmonary edema 
in 1.3% of cases with severe preeclampsia. This result 
is higher than the results found by Yildirim et al. 
(5/903 cases, 0.6%) [15], and lower than the results 
found in Tuffnell et al. (25/1087 cases, 2.3%) [16] 
In our study cesarean delivery rate in severe 
preeclampsia group was 77 %. Similar to our study we 
found increased rates of caesarean section in even in 
the studies of Liu et al. [12Error! Reference source 
not found.] and Murphy and Stirrat [13] (87.3 and 80 
% respectively). In our study 7.8 % of cases with 
severe preeclampsia presented placental abruption 
which is less than the rate of 15% reported by Murphy 
and Stirrat [13]. 
Yildirim et al. in their study found renal failure 
in 14 of 903 cases with severe preeclampsia (1.6%) 
while in our study we found renal failure in 4 of 154 
cases (2.6%) [15]. 
We concluded that severe preeclampsia is 
associated with high rates of maternal severe 
morbidity. Early diagnosis and timely intervention can 
prevent life threating complications from this disorder 
and can improve maternal outcomes.  
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